ArticleAmerican journal of hematology2026

Real-World Evaluation of Talquetamab for the Treatment of Relapsed/Refractory Multiple Myeloma (RRMM): An International Myeloma Working Group Immunotherapy Registry Real-World Analysis.

Murali Janakiram et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.